Oric Pharmaceuticals (ORIC) Change in Accured Expenses (2019 - 2026)

Oric Pharmaceuticals' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 58.01% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 710.06% YoY) and the FY2025 annual result came in at -$7.2 million, down 497.04% from the prior year.
• Change in Accured Expenses was -$3.3 million for Q1 2026 at Oric Pharmaceuticals, down from -$448000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.9 million in Q3 2023 and bottomed at -$7.9 million in Q1 2025.
• A 5-year average of -$408235.3 and a median of -$158000.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 682.2% — and 2024, when it tumbled 627.02%.
• Oric Pharmaceuticals' Change in Accured Expenses stood at $1.4 million in 2022, then slumped by 32.2% to $979000.0 in 2023, then jumped by 209.09% to $3.0 million in 2024, then sank by 114.81% to -$448000.0 in 2025, then tumbled by 641.52% to -$3.3 million in 2026.
• Business Quant data shows ORIC's Change in Accured Expenses at -$3.3 million in Q1 2026, -$448000.0 in Q4 2025, and $1.4 million in Q3 2025.